BioCentury
ARTICLE | Clinical News

Napabucasin: Phase III final data

October 17, 2016 7:00 AM UTC

Sumitomo Dainippon Pharma Co. Ltd. (Tokyo:4506), Osaka, Japan Product: Napabucasin ( BB608, BBI608) Business: Cancer Molecular target: Signal transducer and activator of transcription 3 (STAT3) Des...